If you’ve purchased lab-tested cannabis, you may notice that the most abundant cannabinoid is either THC or THC-A, either of which can stretch between 10-20% on average. While THCA is the more accurate label for flower that hasn’t been decarboxylated, they essentially mean the same thing if you assume the consumer intends on smoking, vaporizing, or heating the product in some way. But what are THCA’s properties if it isn’t converted to THC?
There isn’t enough research on THCA to definitively state what it can treat and with what degree of efficacy, but preliminary research and anecdotal evidence suggest that THCA will play a pivotal role in cannabis medicine as the industry propels forward. Here are some of the potential benefits studies have started to unveil:
Other possible medicinal avenues supported by patient stories include insomnia, muscle spasms, and pain. Unfortunately, we’ll have to wait for more studies to substantiate all of the above benefits before we can fully understand what THCA means for the future of cannabinoid-based medicines.
Every high-THC strain that has not yet been decarboxylated contains THC-A, and these cannabinoid levels are particularly high as a live or freshly harvested plant. For this reason, raw cannabis parts are popularly juiced for their THCA benefits (sweet potato pear smoothie, anyone?).
Some products are marketed specifically for their THCA content. Products like these deliver THCA’s benefits without the risk of psychoactive effects, and as THCA gains traction, we’re likely to find more products like this emerging.